Unlock full details of this profile with our free Lite plan!
Sign Up and Get Free AccessKyron.bio - About the company
Kyron.bio is a seed company based in Paris (France), founded in 2022 by Emilia McLaughlin. It operates as a Developer of bioproduction platform for drug discovery and development. Kyron.bio has raised $6.25M in funding from HCVC. The company has 118 active competitors, including 31 funded and 15 that have exited. Its top competitors include companies like Cyrus Biotechnology, Vividion Therapeutics and Seer.
Company Details
Developer of bioproduction platform for drug discovery and development. It offers a platform that offers a technology that enables the yield of therapeutic proteins produced in mammalian cell factories by harnessing efficient processes from diverse organisms to revolutionize drug production.
- Website
- www.kyron.bio/
- Email ID
- *****@kyron.bio
Key Metrics
Founded Year
2022
Location
Paris, France
Stage
Seed
Total Funding
$6.25M in 4 rounds
Latest Funding Round
Ranked
20th among 118 active competitors
Similar Companies
Get your free copy of Kyron.bio's company profile
Kyron.bio's funding and investors
Filter this listKyron.bio has raised a total funding of $6.25M over 4 rounds. Its latest funding round was a Seed round on May 28, 2025 for $6.25M. 4 investors participated in its latest round, lead by HCVC.
Kyron.bio has 5 institutional investors including HCVC, European Union and Verve Ventures.
Here is the list of recent funding rounds of Kyron.bio:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
May 28, 2025 | $6.25M | Seed | 7078480 | 2658744 | |
Jul 16, 2023 | $84.3K | Grant (prize money) | 4281733 | 1096746 | |
Jul 01, 2023 | $81.9K | Grant (prize money) | 8982734 | 3543405 |
Access funding benchmarks and valuations. Sign up today!View details of Kyron.bio's funding rounds and investors
Kyron.bio's founders and board of directors
Founder? Claim ProfileThe founders of Kyron.bio is Emilia McLaughlin.
View details of Kyron.bio's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Kyron.bio's Competitors and alternates
Top competitors of Kyron.bio include Cyrus Biotechnology, Vividion Therapeutics and Seer. Here is the list of Top 10 competitors of Kyron.bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cyrus Biotechnology 2014, Seattle (United States), Series B | Developer of cloud-based protein-modelling software for drug discovery | $32M | 66/100 | |
2nd | Vividion Therapeutics 2016, Oceanside (United States), Acquired | Developing novel drugs based on a proteome-wide ligand and target discovery platform | $271M | 63/100 | |
3rd | Seer 2017, San Francisco (United States), Public | Developer of proteomics platform for early detection of cancer and neurological diseases | $128M | 62/100 | |
4th | Biognosys 2008, Schlieren (Switzerland), Acquired | Provider of proteomics service | $9.13M | 57/100 | |
5th | ProteinSimple 2004, San Jose (United States), Acquired | Provider tools to help researchers with protein analysis | $94.3M | 56/100 | |
6th | NiKang Therapeutics 2017, Wilmington (United States), Series C | Developer of therapeutics for the treatment of cancer | $260M | 55/100 | |
7th | BridGene Biosciences 2018, Sunnyvale (United States), Series B | Developer of small-molecule drugs for the treatment of cancer | $50.5M | 54/100 | |
8th | Talus 2020, Seattle (United States), Seed | Provider of drug discovery platform for gene regulators | $19.8M | 54/100 | |
9th | Provider of synthetic biology and AI-based technology for generative protein design | $7.73M | 51/100 | ||
10th | ProteinQure 2017, Toronto (Canada), Series A | Provider of computational protein drug design platform | $15M | 51/100 | |
20th | Developer of bioproduction platform for drug discovery and development | $6.25M | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Kyron.bio's competitors? Click here to see the top ones
Kyron.bio's Investments and acquisitions
Kyron.bio has made no investments or acquisitions yet.
Reports related to Kyron.bio
Here is the latest report on Kyron.bio's sector:
News related to Kyron.bio
Media has covered Kyron.bio for 1 event in last 1 year.
•
Female founder in Paris secures €5.5M to advance drug safety with breakthrough biotech platformTech Funding News•May 28, 2025•Kyron.bio
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQ's about Kyron.bio
Explore our recently published companies
- Inovasy - Bekasi based, 2023 founded, Unfunded company
- Bio-F Solutions - London based, 2018 founded, Unfunded company
- Cagen - United Kingdom based, Unfunded company
- Iris Solar Technology - London based, 2023 founded, Unfunded company
- U Credit - 2021 founded, Unfunded company
- Heights - London based, 2018 founded, Unfunded company